News Image

Should you consider NASDAQ:PODD for growth investing?

By Mill Chart

Last update: Nov 28, 2023

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if INSULET CORP (NASDAQ:PODD) is suited for growth investing. Investors should of course do their own research, but we spotted INSULET CORP showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Looking into the growth metrics of INSULET CORP

  • INSULET CORP exhibits a strong Return on Equity (ROE) of 19.75%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
  • INSULET CORP has consistently surpassed EPS estimates in the last 4 quarters, reflecting its strong financial performance and effective management. This trend suggests the company's ability to generate positive earnings surprises and drive shareholder value.
  • INSULET CORP has demonstrated strong 1-year revenue growth of 25.23%, reflecting revenue momentum and its ability to generate consistent top-line expansion. This growth underscores the company's strong market position and its potential for future success.
  • The quarter-to-quarter (Q2Q) revenue growth of 26.97% of INSULET CORP has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and drive revenue growth.
  • INSULET CORP has shown positive growth in its operating margin over the past year, indicating improved operational efficiency. This growth highlights the company's ability to effectively manage costs and maximize profitability.
  • With positive growth in its free cash flow (FCF) over the past year, INSULET CORP showcases its ability to generate strong cash flows and maintain a solid financial position. This growth reflects the company's efficient utilization of capital and its commitment to long-term value creation.
  • The EPS of INSULET CORP has exhibited growth from one quarter to another (Q2Q), with a 103.0% increase. This underscores the company's ability to generate higher earnings and improve its financial standing.
  • Analysts' average next Quarter EPS Estimate for INSULET CORP has witnessed a 16.65% change in the last 3 months, underscoring the dynamic nature of market sentiment towards the company's EPS prospects.
  • In the most recent financial report, INSULET CORP reported a 103.0% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
  • The earnings per share (EPS) growth of INSULET CORP are accelerating: the current Q2Q growth of 103.0% is above the previous year Q2Q growth of 94.44%. Earnings momentum and acceleration are key for high growth systems.

Zooming in on the fundamentals.

ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.

Taking everything into account, PODD scores 6 out of 10 in our fundamental rating. PODD was compared to 202 industry peers in the Health Care Equipment & Supplies industry. While PODD has a great profitability rating, there are some minor concerns on its financial health. PODD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!

Check the latest full fundamental report of PODD for a complete fundamental analysis.

Our Lois Navellier screen will find you more ideas suited for growth investing.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.



NASDAQ:PODD (2/22/2024, 4:30:45 PM)

After market: 190.5 -6.64 (-3.37%)


+4.65 (+2.42%)


News Image2 hours ago - Seeking AlphaInsulet Non-GAAP EPS of $1.40 beats by $0.74, revenue of $509.8M beats by $48.74M (NASDAQ:PODD)

Insulet press release (NASDAQ:PODD): Q4 Non-GAAP EPS of $1.40 beats by $0.74.Revenue of $509.8M (+37.9% Y/Y) beats by $48.74M.Total Omnipod revenue of...

News Image2 hours ago - Insulet CorporationInsulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
News Image5 hours ago - Market News VideoNotable Thursday Option Activity: NEM, PODD, INTU
News Image2 days ago - Market News VideoCommit To Purchase Insulet At $140, Earn 8.7% Annualized Using Options
News Image9 days ago - Insulet CorporationInsulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
News Image15 days ago - Seeking AlphaInsulet gets CE Mark for Ominipod 5 with FreeStyle Libre 2 sensor (NASDAQ:PODD)

Insulet (PODD) has received European approval for its Omnipod 5 insulin delivery system integrated with Abbott's (ABT) FreeStyle Libre 2 Plus sensor for type 1 diabetes.

News Image16 days ago - Insulet CorporationInsulet Announces CE Mark Approval of OmnipodĀ® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
News Imagea month ago - Insulet CorporationInsulet Announces Changes to Board of Directors with Retirements and New Appointments
News Imagea month ago - Market News VideoInsulet Takes Over #420 Spot From Incyte
News Imagea month ago - Insulet CorporationInsulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
News Image2 months ago - Market News VideoThursday Sector Leaders: Healthcare, Financial
PODD Links
Follow us for more